Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?

Gaynes BN, Farley JF, Dusetzina SB, Ellis AR, Hansen RA, Miller WC, Stürmer T.

Depress Anxiety. 2011 Nov;28(11):989-98. doi: 10.1002/da.20898. Epub 2011 Sep 2.

2.

Antidepressants for smoking cessation.

Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T.

Cochrane Database Syst Rev. 2014 Jan 8;(1):CD000031. doi: 10.1002/14651858.CD000031.pub4. Review.

PMID:
24402784
3.

Antidepressant treatment for postnatal depression.

Molyneaux E, Howard LM, McGeown HR, Karia AM, Trevillion K.

Cochrane Database Syst Rev. 2014 Sep 11;(9):CD002018. doi: 10.1002/14651858.CD002018.pub2. Review.

PMID:
25211400
4.

Newer generation antidepressants for depressive disorders in children and adolescents.

Hetrick SE, McKenzie JE, Cox GR, Simmons MB, Merry SN.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD004851. doi: 10.1002/14651858.CD004851.pub3. Review.

PMID:
23152227
5.

Agomelatine versus other antidepressive agents for major depression.

Guaiana G, Gupta S, Chiodo D, Davies SJ, Haederle K, Koesters M.

Cochrane Database Syst Rev. 2013 Dec 17;(12):CD008851. doi: 10.1002/14651858.CD008851.pub2. Review.

PMID:
24343836
6.

Strategies for managing sexual dysfunction induced by antidepressant medication.

Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K.

Cochrane Database Syst Rev. 2013 May 31;(5):CD003382. doi: 10.1002/14651858.CD003382.pub3. Review.

PMID:
23728643
7.

Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.

Edwards SJ, Hamilton V, Nherera L, Trevor N.

Health Technol Assess. 2013 Nov;17(54):1-190. doi: 10.3310/hta17540. Review.

8.

Treatment of antidepressant nonresponders: augmentation or switch?

Nelson JC.

J Clin Psychiatry. 1998;59 Suppl 15:35-41. Review.

9.

Pharmacological interventions for somatoform disorders in adults.

Kleinstäuber M, Witthöft M, Steffanowski A, van Marwijk H, Hiller W, Lambert MJ.

Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628. doi: 10.1002/14651858.CD010628.pub2. Review.

PMID:
25379990
10.

If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies.

Connolly KR, Thase ME.

Drugs. 2011 Jan 1;71(1):43-64. doi: 10.2165/11587620-000000000-00000. Review.

PMID:
21175239
11.

Specificity profile of venlafaxine and sertraline in major depression: metaregression of double-blind, randomized clinical trials.

Gibiino S, Marsano A, Serretti A.

Int J Neuropsychopharmacol. 2014 Jan;17(1):1-8. doi: 10.1017/S1461145713000746. Epub 2013 Aug 19. Review.

PMID:
23953038
12.

Antidepressants for the treatment of depression in people with cancer.

Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M.

Cochrane Database Syst Rev. 2015 Jun 1;(6):CD011006. doi: 10.1002/14651858.CD011006.pub2. Review.

PMID:
26029972
13.

Antidepressants for people with epilepsy and depression.

Maguire MJ, Weston J, Singh J, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD010682. doi: 10.1002/14651858.CD010682.pub2. Review.

PMID:
25464360
14.

Anxiolytic antidepressant augmentation.

Sussman N.

J Clin Psychiatry. 1998;59 Suppl 5:42-8; discussion 49-50. Review.

15.

Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant.

Patel K, Allen S, Haque MN, Angelescu I, Baumeister D, Tracy DK.

Ther Adv Psychopharmacol. 2016 Apr;6(2):99-144. doi: 10.1177/2045125316629071. Epub 2016 Feb 18. Review.

Supplemental Content

Support Center